A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

BACKGROUND: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before initiating treatment with coreceptor antagonists, viral coreceptor usage should be determined to ensure that the virus can use only the CCR5 coreceptor (R5) and cannot evade the drug by using the CXCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Döring, Matthias, Borrego, Pedro, Büch, Joachim, Martins, Andreia, Friedrich, Georg, Camacho, Ricardo Jorge, Eberle, Josef, Kaiser, Rolf, Lengauer, Thomas, Taveira, Nuno, Pfeifer, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168878/
https://www.ncbi.nlm.nih.gov/pubmed/27998283
http://dx.doi.org/10.1186/s12977-016-0320-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168878/
https://www.ncbi.nlm.nih.gov/pubmed/27998283
http://dx.doi.org/10.1186/s12977-016-0320-7

Ejemplares similares